Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
S. H. Ko, P. Radecki, F. Belinky, J. Bhiman, S. Meiring, J. Kleynhans, D. Amoako, V. Guerra Canedo, M. Lucas, D. Kekana, N. Martinson, L. Lebina, J. Everatt, S. Tempia, T. Bylund, , E. A. Boritz
This study shows that advanced HIV infection leads to high intra-host SARS-CoV-2 spike diversity and adaptive evolution, potentially contributing to new variants of concern.
bioRxiv · Jan 5, 2024 · PreprintMicrobiology
L. Liu, S. Iketani, Y. Guo, R. Casner, E. Reddem, M. S. Nair, J. Yu, J. Chan, M. Wang, G. Cerutti, Z. Li, C. Castagna, L. Corredor, H. Chu, S. Yuan, , D. D. Ho
The paper identifies a human monoclonal antibody that neutralizes all tested sarbecoviruses and describes a new antibody class with potential for pandemic preparedness.
bioRxiv · Dec 11, 2021 · PreprintMicrobiology
D. Martinez, A. Schaefer, S. Gobeil, D. Li, G. De la Cruz, R. Parks, X. Lu, M. Barr, K. Manne, K. Mansouri, R. J. Edwards, B. Yount, K. Anasti, S. Montgomery, X. Shen, , R. S. Baric
A broadly neutralizing antibody protects against multiple SARS-CoV and SARS-CoV-2 variants in mice by targeting a conserved epitope in the receptor-binding domain.
bioRxiv · Apr 27, 2021 · PreprintMicrobiology
J. Xu, K. Xu, S. K. Jung, A. Conte, J. Lieberman, F. Muecksch, J. C. C. Lorenzi, S. Park, Z. Wang, L. Tessarollo, T. Bylund, G.-Y. Chuang, A. Olia, I.-T. Teng, T. Zhou, , R. Casellas
This paper isolates and characterizes nanobodies from camelids and engineered mice that neutralize SARS-CoV-2 variants through conserved epitopes and multimeric avidity.
bioRxiv · Mar 4, 2021 · PreprintImmunology